Fundraising FoxB4 Capital — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
.png){kind=icon}
Judi Rx (formerly Capital Rx) is a transparent, fiduciary-aligned pharmacy benefits manager that prices drugs against the federal NADAC benchmark, passes through rebates, and charges a single flat administrative fee.
Digital HealthEnterprise SoftwareHealthtechInsurTechSaaSNew York, US
AJ Loiacono(Co-Founder & CEO)Ryan Kelly(Director)inA. J. Loiacono(Director, Executive Officer)
BoardLenard Marcus(Director)inJared Kesselheim(Director)inKevin Hill(Director)
Board seatRobert Mittendorff· per SEC Form D
Co-investorsB Capital GroupKoru CapitalTRANSFORMATION CAPITALWellington Management9Yards CapitalB Capital+3 more
.jpeg){kind=logo}
Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons.
AI & Machine LearningBiotechHardwareHealthtechMedical DevicesCarlsbad, US
Mike Cordonnier(Co-Founder, President and Chief Executive Officer)inNiall Casey(Co-Founder and Chief Intellectual Property Officer)inShariq Hussain(Chief Technology Officer)inAlexander Arrow(Executive Officer)Sharon Schulzki(Chief Clinical & Market Access Officer)Leo Greenstein(Chief Financial Officer)
Board seatRobert Mittendorff· per SEC Form D
Co-investorsAlliance of AngelsB Capital GroupCove FundDevice of Tomorrow CapitalPasadena AngelsProta Ventures+2 more
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.
Digital HealthHealthtechMedical DevicesMental HealthMclean, US
Mike Suiters(Executive Officer, Director)inNick Whitehead(Director)in
BoardDaniel Gebremedhin(Director)John Banta(Director)inBrenton Fargnoli(Director)in
Board seatAdam SeabrookNick Whitehead· per SEC Form D
Co-investorsAlleyCorpaMoonB Capital GroupFlare Capital PartnersLifeforce CapitalObvious Ventures+3 more
Solve Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADCs) and radiopharmaceuticals for solid tumors, built around its CloakLink hydrophilic cleavable linker platform and an integrated diagnostic for patient selection.
BiotechDeep TechHealthtechBelmont, US
David Johnson(Chief Executive Officer)Clayton Knox(President)Katti Jessen(SVP, Translational Sciences)inYakov Kogan(Head of Operations)Brian Lannutti(Research & Development Leadership)inLangdon Miller(Clinical Development Leadership)
Board seatRobert Mittendorff· per SEC Form D
Co-investorsDecheng CapitalMatrix Capital ManagementYosemiteB Capital Group
Volastra Therapeutics is a drug discovery and development company working on novel cancer therapies.
BiotechHealthtechNew York, US
Samuel Bakhoum(Co-Founder & Chief Scientific Officer)inLewis Cantley(Founder and Chair of Scientific Advisory Committee)Olivier Elemento(Founder and Scientific Advisor)David P. Southwell(Chief Executive Officer)in
BoardJill Goldstein(Director)in
Board seatRobert Mittendorff· per SEC Form D
Co-investorsDroia VenturesARCH Venture PartnersB Capital GroupVida VenturesCatalio Capital ManagementPolaris Partners
Knox Systems helps software companies navigate FedRAMP compliance and secure federal government contracts.
Cloud ComputingCybersecurityGovTechSaaSAustin, US
Irina Denisenko(Chief Executive Officer)inWilliam Christopher Johnson(Executive Officer, Director)
BoardViviana Faga(Director)inCarrie Lee(Federal Advisor)David Epperson(Federal Advisor)Chad Tetrault(Federal Advisor)
Co-investorsB Capital GroupFelicis VenturesM12 (Microsoft's Venture Fund)B CapitalBenchstrength PartnersFirsthandVC+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.